High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Elderly Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma: A Nationwide Retrospective Study

Swerdlow, 2008 Aoki, 2008, Distribution of malignant lymphoma in Japan: analysis of 2260 cases, 2001-2006, Pathol Int, 58, 174, 10.1111/j.1440-1827.2007.02207.x A predictive model for aggressive non-Hodgkin's lymphoma, 1993, The International Non-Hodgkin's Lymphoma Prognostic Factors Project, New Engl J Med, 329, 987 Morton, 2006, Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001, Blood, 107, 265, 10.1182/blood-2005-06-2508 Coiffier, 2002, CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma, New Engl J Med, 346, 235, 10.1056/NEJMoa011795 Sehn, 2005, Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia, J Clin Oncol, 23, 5027, 10.1200/JCO.2005.09.137 Vose, 2001, Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry, J Clin Oncol, 19, 406, 10.1200/JCO.2001.19.2.406 Philip, 1995, Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma, New Engl J Med, 333, 1540, 10.1056/NEJM199512073332305 Mounier, 2012, High-dose therapy and autologous stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era: an analysis based on data from the European Blood and Marrow Transplantation Registry, Biol Blood Marrow Transplant, 18, 788, 10.1016/j.bbmt.2011.10.010 Wildes, 2008, Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma, Biol Blood Marrow Transplant, 14, 840, 10.1016/j.bbmt.2008.05.002 Jantunen, 2008, Autologous stem cell transplantation in elderly patients (> or =60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry, Haematologica, 93, 1837, 10.3324/haematol.13273 Atsuta, 2007, Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System, Int J Hematol, 86, 269, 10.1007/BF03006932 Cheson, 1999, Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group, J Clin Oncol, 17, 1244, 10.1200/JCO.1999.17.4.1244 Imai, 2005, Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution in non-Hodgkin's lymphoma (NHL): results of Japanese phase II study, Bone Marrow Transplant, 35, 479, 10.1038/sj.bmt.1704819 Yamamoto, 2006, LEED therapy followed by auto PBSCT for aggressive and relapsed malignant lymphoma, Rinsho Ketueki, 9, 1022 Fine, 2001, Regression modeling of competing crude failure probabilities, Biostatistics (Oxford, England), 2, 85, 10.1093/biostatistics/2.1.85 Kaplan, 1958, Nonparametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452 Zhang, 2002, Cox proportional hazards regression models for survival data in cancer research, Cancer Treat Res, 113, 59, 10.1007/978-1-4757-3571-0_4 Friedberg, 2011, Relapsed/refractory diffuse large B-cell lymphoma, Hematology Am Soc Hematol Educ Program, 2011, 498, 10.1182/asheducation-2011.1.498 Jantunen, 2006, Autologous stem cell transplantation in elderly (>60 years) patients with non-Hodgkin's lymphoma: a nation-wide analysis, Bone Marrow Transplant, 37, 367, 10.1038/sj.bmt.1705266 Gopal, 2001, Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older, Bone Marrow Transplant, 27, 593, 10.1038/sj.bmt.1702833 Artz, 2006, Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation, Biol Blood Marrow Transplant, 12, 954, 10.1016/j.bbmt.2006.05.015 Sorror, 2005, Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT, Blood, 106, 2912, 10.1182/blood-2005-05-2004 Tucci, 2009, A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy, Cancer, 115, 4547, 10.1002/cncr.24490 Fenske, 2009, Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma, Biol Blood Marrow Transplant, 15, 1455, 10.1016/j.bbmt.2009.07.017 Martin, 2008, R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study, Haematologica, 93, 1829, 10.3324/haematol.13440 Armitage, 2003, Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients, J Clin Oncol, 21, 897, 10.1200/JCO.2003.07.113